Q4 2024 GE Healthcare Technologies Inc Earnings Call Transcript
Key Points
- GE HealthCare Technologies Inc (GEHC) reported strong orders growth across all segments, with a robust backlog and the highest book-to-bill ratio since becoming a public company.
- The company delivered revenue growth driven by demand in Advanced Visualization Solutions and Pharmaceutical Diagnostics, particularly in the US market.
- GEHC achieved significant margin expansion, with an adjusted EBIT margin of 18.7% in the fourth quarter, up 260 basis points year-over-year.
- The company closed 50 enterprise deals globally in 2024, including a $1 billion Care Alliance with Sutter Health, contributing to a solid foundation for future growth.
- GEHC continued to advance its leadership in AI, increasing its AI-enabled FDA authorizations from 58 to 85 within a year, and made strides in cloud-based solutions development.
- Free cash flow decreased by $145 million year-over-year in the fourth quarter, attributed to inventory builds that are expected to be worked down in the first half of 2025.
- Organic revenue growth for 2024 was only 1%, with product revenue flat and service revenue growing by 3%, indicating slower growth compared to previous years.
- The company faced headwinds in the China market, impacting global sales growth by approximately 200 basis points in the fourth quarter.
- Patient Care Solutions segment experienced a decline in EBIT margin by 50 basis points due to inflation and portfolio mix, despite improved fulfillment.
- GEHC's guidance for 2025 reflects a cautious approach, with expected revenue growth of only 2% to 3%, considering potential challenges in the China market and US tariffs.
Good day, and thank you for standing by. Welcome to the GE HealthCare fourth quarter and full year 2024 earnings conference call. (Operator Instructions) Please be advised this conference is being recorded.
I would now like to hand the conference over to your speaker today, Carolynne Borders, please go ahead.
Thanks, operator. Good morning, and welcome to GE HealthCare's fourth quarter 2024 earnings call. I'm joined by our President and CEO, Peter Arduini; and Vice President and CFO, Jay Saccaro.
Our conference call remarks will include both GAAP and non-GAAP financial results. Reconciliations between GAAP and non-GAAP measures can be found in today's press release and in the presentation slides available on our website.
During this call, we'll make forward-looking statements about our performance. These statements are based on how we see things today. As described in our SEC filings, actual results may differ materially due to risks and uncertainties.
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
